{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:15Z","timestamp":1792806195338,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.diabres.2026.113429","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:20:57Z","timestamp":1783603257000},"page":"113429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Meta-analysis of sodium glucose transport 2 inhibitors versus other glucose-lowering agents on the progression of diabetic retinopathy and diabetic macular edema"],"prefix":"10.1016","volume":"239","author":[{"given":"Rukayat","family":"Akande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-6897","authenticated-orcid":false,"given":"Stewart G.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement_1","key":"10.1016\/j.diabres.2026.113429_b0005","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.2337\/dc26-S012","article-title":"12. Retinopathy, neuropathy, and foot care: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Porfessional Practice Committee of Diabetes","year":"2025","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2026.113429_b0010","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc24-2885","article-title":"The NIDDK takes on the complications of type 1 diabetes: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","volume":"48","author":"Braffett","year":"2025","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.diabres.2026.113429_b0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113429_b0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2026.113429_b0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113429_b0030","series-title":"Williams Textbook of Endocrinology","first-page":"1466","article-title":"Complications of diabetes mellitus","author":"Brownlee","year":"2025"},{"issue":"13","key":"10.1016\/j.diabres.2026.113429_b0035","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.diabres.2026.113429_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108255","article-title":"Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - a systematic review and meta-analysis","volume":"36","author":"Yoshida","year":"2022","journal-title":"J Diabetes Complications"},{"issue":"9","key":"10.1016\/j.diabres.2026.113429_b0045","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/dom.13339","article-title":"Glucagon-like peptide-1 receptor expression in the human eye","volume":"20","author":"Hebsgaard","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2026.113429_b0050","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz069","article-title":"Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: the AngioSafe Type 2 Diabetes Study","volume":"105","author":"Gaborit","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2026.113429_b0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dom.13538","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review","volume":"21","author":"Bain","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2026.113429_b0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/dom.13172","article-title":"Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy","volume":"20","author":"Vilsb\u00f8ll","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113429_b0065","article-title":"Glucagon-like peptide 1-receptor agonists and A1c: good for the heart but less so for the eyes? Diabetes & metabolic syndrome","volume":"17","author":"Albert","year":"2023","journal-title":"Clin Res Rev"},{"key":"10.1016\/j.diabres.2026.113429_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8867875","article-title":"The role of SGLT2 inhibitor on the treatment of diabetic retinopathy","volume":"2020","author":"Sha","year":"2020","journal-title":"J Diabetes Res"},{"issue":"7","key":"10.1016\/j.diabres.2026.113429_b0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db22-0970","article-title":"The early pathogenesis of diabetic retinopathy and its attenuation by sodium-glucose transporter 2 inhibitors","volume":"73","author":"Yamato","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113429_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110096","article-title":"The presence of sodium glucose co-transporter 2 in mesangial cells and pericytes and its roles in mesangial lesions and in capillaries under diabetic and ischemic conditions","volume":"192","author":"Wakisaka","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.diabres.2026.113429_b0085","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/dom.16244","article-title":"Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: a randomised clinical trial","volume":"27","author":"Ishibashi","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.diabres.2026.113429_b0090","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1111\/dom.16636","article-title":"Sodium-glucose co-transporter 2 inhibitors reduce the intravitreal anti-VEGF treatment necessity in eyes with early diabetic macular oedema: a post-hoc analysis focusing on the fellow eye of the COMET trial","volume":"27","author":"Tatsumi","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113429_b0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11096-025-02071-2","article-title":"Sodium-glucose cotransporter-2 inhibitors and risk of diabetic retinopathy in type 2 diabetes: a network meta-analysis of randomised clinical trials","volume":"48","author":"Ortiz-Seller","year":"2026","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.diabres.2026.113429_b0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10792-025-03768-z","article-title":"SGLT2 inhibitors for delaying diabetic retinopathy: a systematic review and meta-analysis","volume":"45","author":"Goodarzi","year":"2025","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113429_b0105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/dom.14197","article-title":"Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.diabres.2026.113429_b0110","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/dom.13232","article-title":"Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: a network meta-analysis","volume":"20","author":"Tang","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2026.113429_b0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/M20-0864","article-title":"Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis","volume":"173","author":"Tsapas","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2026.113429_b0120","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Analysing data and undertaking meta-analyses (last updated November 2024)","author":"Deeks","year":"2024"},{"key":"10.1016\/j.diabres.2026.113429_b0125","unstructured":"Higgins JPT, T.J., Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 2021 [cited 2021 (updated February 2021)]; Available from: www.training.cochrane.org\/handbook."},{"key":"10.1016\/j.diabres.2026.113429_b0130","unstructured":"Sterne JAC, H.M., McAleenan A, Reeves BC, Higgins JP. Assessing risk of bias in a non-randomized study in Cochrane Handbook for Systematic Reviews of Interventions T.J. Higgins JP, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s), Editor. 2024."},{"key":"10.1016\/j.diabres.2026.113429_b0135","unstructured":"Higgins JPT, S.J., Page MJ, Elbers RG, Sterne JAC, Revise Cochrane risk of bias tool for randomized trials (RoB2.0) in Cochrane Handbook for Systematic Reviews of Interventions H.M. Sterne JAC, McAleenan A, Reeves BC, Higgins JP, Editor. 2024."},{"issue":"Supplement_1","key":"10.1016\/j.diabres.2026.113429_b0140","first-page":"S183","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142026","volume":"49","author":"Diabetes*, A.D.A.P.P.C.f.","year":"2025","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2026.113429_b0145","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archopht.116.7.874","article-title":"Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial","volume":"116","author":"Group, T.D.C.a.T.R.","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113429_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70184","article-title":"Blood pressure status modulates the therapeutic response to sodium-glucose cotransporter 2 inhibitors in diabetic macular edema: a post hoc subgroup analysis of the COMET Trial","volume":"17","author":"Ishibashi","year":"2025","journal-title":"J Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2026.113429_b0155","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/aos.17473","article-title":"Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association","volume":"103","author":"Amini","year":"2025","journal-title":"Acta Ophthalmol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:15:38Z","timestamp":1792804538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726003499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0168822726003499"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113429","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of sodium glucose transport 2 inhibitors versus other glucose-lowering agents on the progression of diabetic retinopathy and diabetic macular edema","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113429"}}